Patient Perceptions of Switching to a Generic Dry Powder Inhaler – Increased Understanding Through Journey Mapping
Open Access
- 6 August 2022
- journal article
- research article
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 17, 1751-1768
Abstract
Purpose: This qualitative study explored patients’ attitudes about and perceptions of generic dry powder inhaler (DPI) substitution for the brand product and patients’ views of generic product quality, efficacy, design, and usability. Methods: Forty COPD and asthma patients (36 adults, four adolescents), who were actively using a brand DPI product, participated in one of six focus groups. Participants completed a journey mapping exercise to assess attitudes and opinions about a scenario where they refill their prescription and unexpectedly receive a generic DPI instead of their brand DPI. The focus groups were audio recorded, transcribed, and analyzed thematically. Results: The hypothetical scenario of unexpectedly receiving a generic DPI elicited mixed feelings including: happiness and relief about potential cost savings, confusion, disappointment, anger, and/or frustration with the unexpected switch. Participants in most groups anticipated anxiety or hesitation in using the generic DPI due to concerns about potential differences in usability, uncertainty about correct use, and questions about efficacy. Participants across all groups said they would ask a pharmacist or healthcare provider for information or answers to their questions, and some participants said they would use online resources. When participants held the brand and generic DPI devices, most preferred the brand DPI device and found it easier, less cumbersome, or more convenient to use (due to size and weight). However, many participants reiterated that the potential reduced cost of the generic DPI would be a primary factor in their decision-making related to generic DPI substitution for their brand DPI. Conclusion: Patients experienced a mixture of positive and negative feelings when faced with an unexpected generic DPI substitution. Some patients have doubts about their ability to successfully navigate differences in generic device design, and most expressed the desire to participate in discussions and decision-making with their HCP about generic DPI sameness and substitution.Keywords
This publication has 38 references indexed in Scilit:
- Perceptions of and Barriers to Use of Generic Medications in a Rural African American Population, Alabama, 2011Preventing Chronic Disease, 2012
- What happens to patients who have their asthma device switched without their consent?Primary Care Respiratory Journal, 2010
- Patientsʼ Attitudes towards Generic Substitution of Oral Atypical AntipsychoticsCNS Drugs, 2009
- Assessing lay beliefs about generic medicines: Development of the generic medicines scalePsychology, Health & Medicine, 2009
- Patients’ Perceptions Of Generic MedicationsHealth Affairs, 2009
- Cost-Related Medication Underuse: A Window Into Patients' Medication-Related ConcernsDiabetes Spectrum, 2009
- Beliefs about generic drugs among elderly adults in hospital-based primary care practicesPatient Education and Counseling, 2008
- Handling of and Preferences for Available Dry Powder Inhaler Systems by Patients with Asthma and COPDJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2008
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006
- Do patients think that dry powder inhalers can be used interchangeably?International Journal Of Clinical Practice, 2005